Fc Receptor Signaling in Vaccine Design for the Elderly
Fc Receptor Signaling in Vaccine Design for the Elderly
批准号:
7196535
负责人:
Biao Zheng
金额:
$39.98万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-01 至 2010-02-28
关键词:
AccountingAgeAge-YearsAgingAntibody FormationAntigen-Antibody ComplexAntigensCellsCessation of lifeChronicCommunicable DiseasesConditionDendritic CellsEffectivenessElderlyEventFc ReceptorHumoral ImmunitiesImmuneImmune responseImmune systemImmunizationInfectionInfluenzaInfluenza vaccinationLinkModelingMorbidity - disease rateMusPersonsPopulationPredispositionRNA InterferenceReceptor SignalingRiskSignal TransductionSmall Interfering RNATechniquesTestingVaccinationVaccine DesignVaccinesVirusVirus Diseasesage relatedagedimmune functionimmunosenescenceinfluenza virus vaccineinfluenzavirusmortalitynovelpreventresponsevaccination strategy
中文摘要
描述(由申请人提供):在老年人中,细胞和体液免疫均显著下降,导致免疫功能失调或免疫衰老。免疫衰老损害了对传染病的保护,并导致老年人对感染的易感性增加。此外,免疫衰老是老年人对疫苗接种反应性降低的原因。因此,老年人特别脆弱,在发生生物恐怖袭击时面临更大的风险。老年人对流感病毒感染和疫苗接种的反应受损可能与临床最相关。老年人对流感疫苗接种的反应明显受损。老年人对流感疫苗接种的第一和第二抗体反应都减弱。即使流感疫苗和流行病毒之间的抗原匹配非常接近,接种疫苗也只能为年龄≥ 65岁的受试者提供30%- 40%的保护,而年龄< 65岁的受试者则为70%-90%。目前可用的三价灭活流感疫苗在预防患有相关慢性病的老年人死亡方面特别无效,这突出表明需要对最需要的老年人更有效的流感疫苗。
Fc受体(FcR)连接免疫系统的体液和细胞分支,并且在免疫应答的激活和调节中具有关键功能。我们最近的研究表明,免疫复合物(IC)可以纠正小鼠对模型抗原以及流感疫苗的体液和细胞免疫应答中与年龄相关的缺陷。我们还证明了抑制性Fc受体Fc γ IIB可以通过使用小干扰RNA(siRNA)的RNA干扰来选择性地消融。因此,操纵FcR信号和IC疫苗接种可能构成一种新的免疫策略,以提供有效的保护免疫受损的老年人群免受流感感染。在这个项目中,我们提出以下具体目标:
目标1。确定IC调节免疫应答的机制
目标二。研究通过选择性信号传导Fc受体调节免疫应答
目标3。确定1C疫苗在克服年龄相关免疫缺陷方面的有效性。
英文摘要
DESCRIPTION (provided by applicant): In the elderly, there is a significant decline in both cellular and humoral immunity, leading to a state of dysregulated immune functions, or immunosenescence. Immunosenescence compromises protection against infectious diseases and contributes to the increased susceptibility of the elderly to infection. Furthermore, immunosenescence is responsible for the diminished responsiveness of the elderly to vaccination. Thus, the elderly are particularly vulnerable and are at greater risk in the event of a bioterror attack. An impaired response to influenza virus infection and vaccination in the elderly may be clinically most relevant. The responses to influenza vaccination are significantly impaired in aged people. Both primary and secondary antibody responses to influenza vaccination are diminished in the elderly. Even when the antigenic match between influenza vaccine and circulating virus is close, vaccination provides protection for only 30%- 40% of subjects aged >= 65 years, compared with 70-90% of those aged < 65 years. The currently available trivalent inactivated influenza vaccines are particularly ineffective in preventing deaths among elderly persons with associated chronic conditions, underscoring the need for influenza vaccines that are more effective in elderly persons who need them most.
Fc receptors (FcR) link the humoral and cellular branches of the immune system and have crucial functions in the activation and modulation of immune responses. Our recent studies indicate that immunization with immune complexes (IC) can correct the age-related deficiency in humoral and cellular immune responses to model antigens as well as influenza vaccines in mice. We have also demonstrated that the inhibitory Fc receptor, Fcgamma IIB, can be selectively ablated by RNA interference using small interfering RNA (siRNA). Thus, manipulating FcR signaling and vaccination with IC may constitute a novel immunization strategy to provide effective protection to immune compromised elderly population against influenza infection. In this project, we propose the following specific aims:
Aim 1. Determine the mechanisms by which immune responses are regulated by IC
Aim 2. Study the modulation of immune responses by selective signaling Fc receptors
Aim 3. Determine the effectiveness of 1C vaccines in overcoming age-related immune deficiency.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:8128041
-
项目类别:
-
资助金额:$16.13万
-
财政年份:2010
-
负责人:Biao Zheng
-
依托单位:
Mechanisms of Continued Tolerance Breakdown in Autoimmunity
-
批准号:7456501
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2007
-
负责人:Biao Zheng
-
依托单位:
Mechanisms of Continued Tolerance Breakdown in Autoimmunity
-
批准号:7212509
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2007
-
负责人:Biao Zheng
-
依托单位:
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:7281506
-
项目类别:
-
资助金额:$2.42万
-
财政年份:2006
-
负责人:Biao Zheng
-
依托单位:
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:7070016
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2005
-
负责人:Biao Zheng
-
依托单位:
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:7386530
-
项目类别:
-
资助金额:$39.33万
-
财政年份:2005
-
负责人:Biao Zheng
-
依托单位:
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:6969519
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2005
-
负责人:Biao Zheng
-
依托单位:
Fc Receptor Signaling in Vaccine Design for the Elderly
-
批准号:7595082
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2005
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6706691
-
项目类别:
-
资助金额:$3.94万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6135462
-
项目类别:
-
资助金额:$22.17万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6501787
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6607238
-
项目类别:
-
资助金额:$22.77万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6169483
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6372387
-
项目类别:
-
资助金额:$21.46万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
IMMUNOSENESCENCE AND ALTERED GERMINAL CENTER RESPONSE
-
批准号:6509668
-
项目类别:
-
资助金额:$22.11万
-
财政年份:1999
-
负责人:Biao Zheng
-
依托单位:
AGING EFFECTS ON T CELL SELECTION
-
批准号:2002149
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1996
-
负责人:Biao Zheng
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: